VAERS reports by lot

Novartis Vaccines Meningococcal lot XX33P: VAERS reports

24 VAERS reports list lot XX33P as a Novartis Vaccines Meningococcal vaccine, received between 2023-05-16 and 2024-10-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2853%
Gastrointestinal611%
Neurological59%
Allergic / Anaphylactic59%
Musculoskeletal36%
General / Systemic (non-local)36%
Cardiac / Cardiovascular12%
Dermatological (non-injection-site)12%
Reproductive / Menstrual12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan4
Texas3
Missouri2
New York2
Nevada2
Tennessee1
Virginia1
Connecticut1
Illinois1
Washington1
Idaho1
New Mexico1

Reports by month received

2023-051
2023-072
2023-092
2023-103
2023-116
2023-122
2024-021
2024-031
2024-041
2024-061
2024-082
2024-102

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.